Blue J
Blue J is an AI tax research platform that answers tax law questions for accounting and law firms.
Medxprts.AI
Medxprts.AI develops AI-based software for medical-legal documentation, automating workflow tasks for medical experts in healthcare, legal technology, and professional services contexts.
Blue J vs Medxprts.AI
At a Glance
| Detail | Blue J | Medxprts.AI |
|---|---|---|
| Category | Research & Analytics | Research & Analytics |
| Total raised | $298M | Not disclosed |
| Rounds tracked | 2 | Not disclosed |
| Latest round | Series E, $176M · Nov 2026 | Not disclosed |
| Last valuation | $700M | Not disclosed |
| Lead investors | JMI Equity, Oak HC/FT, Sapphire Ventures | Not disclosed |
| Built for | In-house teams, Large firms, Mid-size firms | Not disclosed |
| Headquarters | Canada | Not disclosed |
Funding, Side by Side
Blue J rounds
- Nov 2026Series E$176M
- Aug 2025Series D$122M
Medxprts.AI rounds
No public rounds tracked yet.
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Blue J or Medxprts.AI?
- Blue J has raised $298M in disclosed funding, compared with no disclosed amount for Medxprts.AI.
- What is Blue J best for?
- Blue J is an AI tax research platform that answers tax law questions for accounting and law firms.
- What is Medxprts.AI best for?
- Medxprts.AI develops AI-based software for medical-legal documentation, automating workflow tasks for medical experts in healthcare, legal technology, and professional services contexts.
Source: Legal Tech Circle funding data, from public announcements. Updated November 12, 2026.